Proactive Investors - Run By Investors For Investors

NMC Health notches up bumper year as acquisition spree continues

Over a third of its licensed bed capacity is in Saudi Arabia
NMC operates in 13 countries

Middle East-focused hospital operator group NMC Health plc (LON:NMC) lifted revenues by a third and predicted another strong year ahead as more sites come on stream.

“Sustained ramp-up of utilisation at facilities we opened in recent years, integration of acquired assets and continued discipline in organic and inorganic expansions should all translate into a very promising 2018 and beyond,” said Prasanth Manghat, chief executive.

“The most important assets to keep a track of in this regard are: NMC Royal, Brightpoint and Chronic Care for ramp-up of operations, Al Zahra Hospital and CosmeSurge from an integration standpoint and the GCC [Gulf Co-operation Council] in general and KSA [Saudi Arabia] in particular for additional acquisitions as we continue to see the benefit from acquiring assets and optimising their capabilities within the NMC network/model.”

READ: FTSE 100 stocks you should have bet your house on in 2017

NMC operates 125 hospitals and clinics across 13 countries and is also one of the world’s top 3 in-vitro fertilisation operators. Over a third of its licensed bed capacity is in Saudi Arabia.

Sales at the FTSE 100 group rose to US$1.6bn (US$1.22bn) in the year to December, while underlying profits [EBITDA] rose 43% to US$353mln.

The dividend rises by 20% to 13p.

Shares eased 2.6% to 3,272p.

View full NMC profile View Profile

NMC Health plc Timeline

Related Articles

October 23 2017
The company is poised for a milestone-rich period over the next year or so
the word antioxidant
August 15 2017
The heparin test is the firm’s lead product; however the company’s OxiChek device for oxidative stress is also gaining traction
Frosties Box
December 04 2017
The company is a pioneer in the human microbiome, which is essentially the bacteria that inhabits the gut and skin

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use